Down-regulation of programmed cell death 4 leads to epithelial to mesenchymal transition and promotes metastasis in

Qing Wang1, Jiang Zhu, Yong Zhang

  • 1Graduate Center for Toxicology, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.

European Journal of Cancer (Oxford, England : 1990)
|January 15, 2013
PubMed

Insights

Knockdown of programmed cell death 4 (Pdcd4) promotes cancer cell migration and metastasis by inducing epithelial to mesenchymal transition (EMT). This suggests Pdcd4 is a key regulator in tumor progression and metastasis.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Programmed cell death 4 (Pdcd4) is a known tumor suppressor.
  • The role of Pdcd4 in epithelial to mesenchymal transition (EMT) and metastasis is not fully understood.

Purpose of the Study:

  • To investigate the role of Pdcd4 in regulating EMT, cell migration, and metastasis.
  • To elucidate the molecular mechanisms by which Pdcd4 influences tumor progression.

Main Methods:

  • In vitro and in vivo experiments involving Pdcd4 knockdown in GEO cells.
  • Wound-healing and Boyden chamber migration assays.
  • Orthotopic implantation in nude mice followed by immunohistochemical analysis.

Main Results:

  • Pdcd4 knockdown induced EMT, characterized by decreased epithelial and increased mesenchymal markers.
  • Pdcd4 knockdown enhanced cell migration and altered extracellular matrix adhesion.
  • Orthotopic implantation of Pdcd4 knockdown cells resulted in increased hepatic and lymph node metastasis.
  • Upregulation of c-Myc and Snail/Slug was observed in tumors with Pdcd4 knockdown.

Conclusions:

  • Pdcd4 knockdown promotes EMT, cell migration, and metastasis.
  • The pro-metastatic effects of Pdcd4 knockdown are mediated by the upregulation of c-Myc and Snail/Slug.
  • Pdcd4 is a critical suppressor of cancer cell migration and metastasis, making it a potential therapeutic target.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...